Hans Christian Tho Slashedgersen

Title: The Innovations of Hans Christian Tho Slashedgersen

Introduction

Hans Christian Tho Slashedgersen is a notable inventor based in Sawston, GB. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant fusion proteins. His work has implications for various applications in medicine and research.

Latest Patents

Slashedgersen holds a patent for recombinant fusion proteins. This invention provides a DNA sequence coding for a cleavage site that is specifically cleaved by blood coagulation Factor Xa. The patent includes a vector containing such a sequence and a host organism transformed with that vector. The Factor Xa cleavage site coding sequence is fused at one end to a product and at its other end to an ATG codon or a sequence coding for at least part of a host protein. This invention also outlines a process for producing a desired protein or peptide product in its native form.

Career Highlights

Slashedgersen is associated with Celltech Therapeutics Limited, a company known for its innovative approaches in biotechnology. His work at Celltech has allowed him to focus on the practical applications of his inventions in the pharmaceutical industry.

Collaborations

He has collaborated with Kiyoshi Nagai, further enhancing the research and development efforts in their field.

Conclusion

Hans Christian Tho Slashedgersen's contributions to biotechnology through his patent on recombinant fusion proteins exemplify the innovative spirit of modern inventors. His work continues to influence advancements in medical research and applications.